Benutzer: Gast  Login
Titel:

Insights into incretin-based therapies for treatment of diabetic dyslipidemia.

Dokumenttyp:
Journal Article; Review
Autor(en):
Stemmer, Kerstin; Finan, Brian; DiMarchi, Richard D; Tschöp, Matthias H; Müller, Timo D
Abstract:
Derangements in triglyceride and cholesterol metabolism (dyslipidemia) are major risk factors for the development of cardiovascular diseases in obese and type-2 diabetic (T2D) patients. An emerging class of glucagon-like peptide-1 (GLP-1) analogues and next generation peptide dual-agonists such as GLP-1/glucagon or GLP-1/GIP could provide effective therapeutic options for T2D patients. In addition to their role in glucose and energy homeostasis, GLP-1, GIP and glucagon serve as regulators of lip...     »
Zeitschriftentitel:
Adv Drug Deliv Rev
Jahr:
2020
Band / Volume:
159
Seitenangaben Beitrag:
34-53
Volltext / DOI:
doi:10.1016/j.addr.2020.05.008
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/32485206
Print-ISSN:
0169-409X
TUM Einrichtung:
Lehrstuhl für Stoffwechselerkrankungen (Prof. Tschöp)
 BibTeX